AGUIAR ERIC

CIK 00012623252 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001262325

Recent Transactions

50 trades

Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+2,234,666→ 2,234,666 total
Purchase
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02$7.00/sh+357,100→ 4,058,432 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series A Convertible Preferred
2004-06-02−8,380,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+1,466,666→ 3,701,332 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series A Convertible Preferred
2004-06-02−8,380,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+1,466,666→ 3,701,332 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series B Convertible Preferred
2004-06-02−5,500,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series B Convertible Preferred
2004-06-02−5,500,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series B Convertible Preferred
2004-06-02−5,500,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series A Convertible Preferred
2004-06-02−8,380,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+2,234,666→ 2,234,666 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+2,234,666→ 2,234,666 total
Purchase
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02$7.00/sh+357,100→ 4,058,432 total
Purchase
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02$7.00/sh+357,100→ 4,058,432 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+1,466,666→ 3,701,332 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+2,234,666→ 2,234,666 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+1,466,666→ 3,701,332 total
Purchase
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02$7.00/sh+357,100→ 4,058,432 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series A Convertible Preferred
2004-06-02−8,380,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series B Convertible Preferred
2004-06-02−5,500,000→ 0 total
Purchase
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02$7.00/sh+357,100→ 4,058,432 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series A Convertible Preferred
2004-06-02−8,380,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series B Convertible Preferred
2004-06-02−5,500,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+2,234,666→ 2,234,666 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+1,466,666→ 3,701,332 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+2,234,666→ 2,234,666 total
Conversion
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02+1,466,666→ 3,701,332 total
Purchase
CORNERSTONE THERAPEUTICS INC
Common Stock
2004-06-02$7.00/sh+357,100→ 4,058,432 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series A Convertible Preferred
2004-06-02−8,380,000→ 0 total
Conversion
CORNERSTONE THERAPEUTICS INC
Series B Convertible Preferred
2004-06-02−5,500,000→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series C Convertible Preferred
2003-10-22−2,588,322→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series E Convertible Preferred
2003-10-22−2,869,252→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series D Convertible Preferred
2003-10-22−3,883,508→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Common Stock
2003-10-22+5,532,486→ 5,532,486 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series B Convertible Preferred
2003-10-22−783,810→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series D Convertible Preferred
2003-10-22−3,883,508→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Common Stock
2003-10-22+5,532,486→ 5,532,486 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series E Convertible Preferred
2003-10-22−2,869,252→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series B Convertible Preferred
2003-10-22−783,810→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series C Convertible Preferred
2003-10-22−2,588,322→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series E Convertible Preferred
2003-10-22−2,869,252→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series B Convertible Preferred
2003-10-22−783,810→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series D Convertible Preferred
2003-10-22−3,883,508→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Common Stock
2003-10-22+5,532,486→ 5,532,486 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series C Convertible Preferred
2003-10-22−2,588,322→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Common Stock
2003-10-22+5,532,486→ 5,532,486 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series E Convertible Preferred
2003-10-22−2,869,252→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series D Convertible Preferred
2003-10-22−3,883,508→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series C Convertible Preferred
2003-10-22−2,588,322→ 0 total
Conversion
MiddleBrook Pharmaceuticals, Inc.
Series B Convertible Preferred
2003-10-22−783,810→ 0 total

Companies

Recent Filings

4
LITTLECHILD JOHN W
Jun 2, 2004

Address

C/O HEALTHCARE VENTURES LLC 44 NASSAU STREET

PRINCETON, NJ, 08542

View on SEC.gov